Hyaluronic Acid Hydration Serum: Molecular Weight Selection & Skin Penetration Data

Overview #

If a brand comes to us asking for “a hyaluronic acid serum,” the first thing we ask is: what molecular weight, and what do you actually want it to do? That question alone filters out half the confusion. Low-molecular-weight HA penetrates the epidermis and drives measurable hydration at the dermal-epidermal junction. High-molecular-weight HA sits on the surface, forms a film, and protects the barrier. Neither is better. They solve different problems, and combining them without understanding the ratio is where most formulations fall flat.

We’ve been formulating HA-based serums for over a decade, and the molecular weight decision is genuinely the most consequential one in the brief. Get it wrong and you have a product that feels nice on application but shows nothing in a consumer perception study at week 4. Get it right and you have a serum that performs in clinical testing and holds up in stability.

Molecular Weight Grades: What We Actually Work With #

The HA market is not as simple as “high vs. low.” In our lab, we routinely work across five distinct MW grades, each with a different skin interaction profile and a different price point.

High-MW HA (1,500–2,500 kDa) is the workhorse of surface hydration. It doesn’t penetrate — it’s physically too large. What it does is form a viscoelastic film on the stratum corneum that reduces transepidermal water loss (TEWL) by roughly 20–30% in our in-house occlusion testing. Consumers feel it immediately. That immediate slip and plump is almost entirely this fraction.

Medium-MW HA (100–500 kDa) is where things get interesting. It has partial penetration capacity, reaching the upper epidermis in ex vivo tape-stripping studies. We use it as the “bridge” fraction — it contributes to both surface feel and subsurface hydration. Honestly, most brands underestimate how much formulation work this grade requires. It’s more sensitive to pH and ionic strength than the high-MW fraction, and we’ve seen viscosity drift in finished product when the buffer system isn’t tight.

Low-MW HA (10–50 kDa) penetrates into the viable epidermis. The penetration data is real — Franz cell studies using radiolabeled HA at this MW range consistently show dermal accumulation at 24 hours. We use it at 0.1–0.5% in the water phase, always buffered to pH 5.5–6.0. Below pH 5.0, we start seeing chain scission on accelerated stability, which degrades the MW profile and kills the clinical story.

Oligomeric HA (below 10 kDa, sometimes called HA oligomers or “nano-HA”) is the most aggressive penetrator. It reaches the dermis in some models. It’s also the most expensive fraction — roughly 4–6× the cost of standard high-MW HA per kilogram — and the regulatory picture in the EU is worth watching. The SCCS Scientific Opinion on nanomaterials applies when particle size drops below 100 nm, and some suppliers’ nano-HA preparations sit right at that boundary. We always ask for supplier documentation on this before we spec it.

Sodium hyaluronate (the salt form) is what most of these grades are actually sold as. It’s more stable in aqueous solution than free hyaluronic acid, and it’s what we use in 95% of our formulations. The MW designation still applies — sodium hyaluronate at 1,500 kDa behaves like high-MW HA.

Penetration Data and What It Actually Means for Claims #

The clinical evidence on HA penetration is more nuanced than supplier decks suggest. The most cited head-to-head data we reference internally comes from a double-blind, vehicle-controlled study (n=33, 8 weeks, twice-daily application) comparing a multi-MW HA serum (combining 1,500 kDa + 50 kDa + 10 kDa fractions) against a single high-MW HA control. The multi-MW group showed a 28% improvement in corneometer readings at week 4 and a 41% improvement at week 8. The high-MW-only control showed 19% at week 4 and 24% at week 8. The difference at week 8 was statistically significant (p<0.05). What the study doesn’t tell you — and what we’ve learned from our own batches — is that the multi-MW blend is significantly harder to stabilize. The low-MW fraction is the weak link.

We’re still not fully convinced the dermis-penetration story for oligomeric HA translates cleanly from ex vivo Franz cell models to real in-use conditions. The skin barrier in a living subject is more dynamic. Our own in-house tape-stripping data on low-MW HA (10 kDa) shows consistent epidermal accumulation, but the dermal signal is variable. We report it honestly to brand partners rather than overselling it.

For on-pack claims, the EU Cosmetics Regulation 1223/2009 requires that any claim be substantiated. “Deeply hydrating” is a cosmetic claim and generally defensible with corneometer data. “Penetrates to the dermis” starts to sound like a drug claim in some markets. We’ve had that conversation with brand partners more than once. The FDA Cosmetics Guidelines draw a similar line — if the product is claimed to affect the structure or function of skin at a cellular level, you’re in drug territory.

For brands targeting the Chinese market, the NMPA Cosmetic Regulation has specific requirements around efficacy substantiation for functional claims. HA-based hydration claims are generally well-supported by the approved claim categories, but the testing protocols need to match NMPA-accepted methods. We handle this in-house for clients filing in China.

Where Most Brands Get This Wrong #

The brief usually says: “We want three molecular weights for maximum penetration.” That sounds right. It’s often wrong.

The problem is that high-MW HA and low-MW HA compete in the same aqueous phase. High-MW HA is a viscosity builder — at 1.0%, it creates a gel matrix that physically impedes the diffusion of low-MW fractions toward the skin surface. We’ve run internal diffusion studies where increasing high-MW HA from 0.5% to 1.2% in a multi-MW blend reduced the flux of the 10 kDa fraction by approximately 35%. That’s a real formulation trade-off that doesn’t show up in supplier blend recommendations.

The fix is phase separation or sequential application — but that’s a product architecture decision, not just a formulation one. Some of our clients have moved to two-step systems (a low-MW HA essence followed by a high-MW HA serum) specifically because of this. It adds SKU complexity and cost, but the performance story is cleaner.

The other failure mode we see regularly: brands request a “waterless HA serum” or a highly concentrated HA powder format. Worked fine at 500g lab scale. At 200kg production, we had one batch where the high-MW HA didn’t fully hydrate in the mixing vessel — we got undissolved polymer aggregates that passed visual QC but failed texture analysis. We now require a minimum 4-hour hydration hold at 40°C with low-shear mixing before any other phase addition. That’s not in any supplier technical sheet. It’s something we learned the hard way.

Preservation is the other thing. HA serums are high-water-activity products, typically Aw >0.97. A lot of clean beauty brands want to avoid traditional preservatives — phenoxyethanol, parabens — and go with “natural” systems like ethylhexylglycerin or glyceryl caprylate. Those systems can work, but they’re pH-sensitive and they need to be validated at the actual production scale. We’ve seen gram-negative contamination appear at week 8 of preservative challenge testing on “natural” preserved HA serums that passed at lab scale. The water activity and the pH interaction at scale is different from a 100g bench batch. This is usually where projects go sideways.

See our detailed notes on encapsulation technology for actives if you’re considering encapsulated HA fractions — the cost and stability implications are significant.

Stability, pH, and the Numbers That Matter #

HA is stable across a fairly wide pH range — 5.0 to 7.5 is our working window. Outside that, you get problems. Above pH 7.5, the sodium hyaluronate salt is stable but the formulation often isn’t — you’re fighting microbial risk and ingredient incompatibility. Below pH 4.5, you get acid-catalyzed hydrolysis of the glycosidic bonds, which degrades MW over time. We’ve seen a 1,500 kDa HA drop to below 800 kDa after 12 weeks at 40°C when the formula pH was 4.2. That’s a meaningful change — the rheology shifts, the skin feel changes, and the clinical story you built around the MW profile is no longer accurate.

Temperature is the other variable. Our standard accelerated stability protocol follows ICH Stability Guidelines — 40°C/75% RH for 6 months, with intermediate conditions at 25°C/60% RH. HA serums generally perform well at 25°C. The 40°C condition is where MW degradation and microbial risk both accelerate. We always run MW verification (by GPC or viscometry) at the 3-month and 6-month timepoints, not just visual and pH checks.

Packaging matters more than most brands expect. UV exposure degrades HA — we’ve measured a 15% viscosity drop in clear glass packaging after 4 weeks of simulated UV exposure versus amber glass controls. Airless pump packaging is ideal for preservation and UV protection, but it adds $0.40–$0.80 per unit at typical MOQ. Most indie brands at MOQ 3,000 units can absorb that. At MOQ 1,000, it’s a harder conversation.

For brands building a full hydration-focused line, our hydration and moisture formulation resources cover the broader ingredient ecosystem — ceramides, humectant layering, and barrier-repair actives that work alongside HA.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask in every HA serum brief.

If you’re targeting a K-beauty-influenced market and want a lightweight essence texture with a “water-burst” feel, we’re looking at a low-viscosity system — high-MW HA at 0.3–0.5%, low-MW HA at 0.2–0.3%, and a humectant base of glycerin at 3–5%. That’s a very different brief from a clinical-positioning serum for a dermatology brand, where we’d push the low-MW fraction higher, add a peptide co-active, and build the stability package around a tighter pH window of 5.5–6.0.

Texture is a claim vehicle. If the product feels immediately plumping, consumers believe it’s working — and for high-MW HA, they’re right, it is working, just at the surface. If the brand story is about “deep hydration” or “cellular moisture,” we need the low-MW fraction to be doing real work, and we need the clinical data to back it. We can design the study, but the brand needs to budget for it — a basic corneometer/TEWL study runs 8–12 weeks and costs more than most indie brands expect.

One thing we push back on regularly: brands who want to list HA first or second on the INCI. That requires concentrations above 1.5–2.0% for high-MW HA, which creates a very heavy, tacky texture that most consumers don’t like. The performance is not linear with concentration above 1.0%. We almost always recommend 0.5–1.0% total HA across all fractions, with the texture story built through the humectant and emollient system.

Frequently Asked Questions #

Q: We want to call it a “triple molecular weight hyaluronic acid serum” — is that a real thing or just marketing?

It’s real if you actually use three distinct MW fractions and can document them. We formulate these regularly — typically 1,500 kDa + 100 kDa + 10 kDa. The challenge is that the claim needs to be substantiated under EU Regulation 1223/2009, so you need supplier CoAs showing the MW ranges for each fraction. Don’t just blend two HA grades and call it triple-weight.

Q: How much HA do we actually need? Our competitor lists it at 2% on their website.

Honestly, 2% total HA is on the high end and usually creates a tacky, heavy texture unless the MW is very low. In most of our serums, total HA across all fractions sits at 0.5–1.2%. The performance difference between 1.0% and 2.0% high-MW HA is minimal — you’re mostly adding cost and texture problems. What matters more is the MW selection and the supporting humectant system.

Q: Can we combine HA with vitamin C in the same serum?

You can, but the pH window is tight. Ascorbic acid is most stable below pH 3.5, and HA starts degrading meaningfully below pH 4.5. We typically land at pH 4.0–4.5 as a compromise, which is suboptimal for both actives. Our usual recommendation is to use a stabilized vitamin C derivative — ascorbyl glucoside or 3-O-ethyl ascorbic acid — which allows a pH of 5.0–5.5 where HA is fully stable. See our vitamin C and antioxidant systems documentation for the full compatibility matrix.

Q: What’s the minimum order quantity for a custom HA serum, and does MW selection affect MOQ?

Our standard MOQ is 1,000 units for a custom serum. MW selection doesn’t change the MOQ, but it does affect lead time — low-MW and oligomeric HA fractions have longer procurement lead times (typically 4–6 weeks versus 1–2 weeks for standard high-MW HA). If you’re using nano-HA or oligomeric fractions, budget an extra 3–4 weeks for raw material qualification.

Q: We’ve seen “fermented hyaluronic acid” on some products — is that different?

Fermented HA is produced via bacterial fermentation (typically Streptococcus zooepidemicus or recombinant Bacillus subtilis), which is actually the standard production method for most pharmaceutical and cosmetic-grade HA. The “fermented” label is mostly a marketing angle — it signals natural origin and resonates with microbiome-conscious consumers. The MW profile and performance are determined by the fermentation and purification process, not the fermentation label itself. What matters is the MW specification on the CoA, not the production method descriptor.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.